Skip to main content
SpringerLink
Log in

Gout and other crystal-deposition disorders

  • Chapter
Therapeutics in Rheumatology

  • 62 Accesses

Abstract

The three main crystal-deposition disorders encountered in clinical practice are those associated with urate, pyrophosphate, and hydroxyapatite. The three types of crystal deposited in relation to tissues of the locomotor system are characterized by somewhat different clinical presentations and therapeutic needs. Although this chapter will be largely devoted to the ‘classical’ crystal deposition disease, urate gout, brief comments will also be made on the management of other crystal-deposition states the rheumatologist is likely to encounter in clinical practice.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 39.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  • Auerbach, R. and Orentrich, N. (1968) Alopecia and ichthyosis secondary to allopurinol. Arch. Dermatol., 98, 104.

    Article  PubMed  CAS  Google Scholar 

  • Bayliss, R., Clarke, C., Whitehead, T. P. and Whitfield, A. G. W. (1984) The management of hyperuricaemia. J. R. Coll. Phys. Lond., 18, 144–6.

    CAS  Google Scholar 

  • Begemann, H. and Neu, I. (1975) Die behandlung der urikopathie mit benz bromaronum unter besonderer berucksichtigune der neireninsuffizienz. Therapie, 25, 2184–94.

    Google Scholar 

  • Boardman, P. L. and Hart, F. D. (1967) Side effects of indomethacin. Ann. Rheum. Dis., 26, 127–32.

    Article  PubMed  CAS  Google Scholar 

  • Boger, W. P. and Strickland, S. C. (1955) Probenecid (Benemid) . Arch. Intern. Med., 95, 83–92.

    Article  CAS  Google Scholar 

  • Brenner, W. J. and Paulsen, C. A. (1976) Colchicine and testicular function in man. N. Engl. J. Med., 294, 1384–5.

    Article  Google Scholar 

  • Brewis, I., Ellis, R. M. and Scott, J. T. (1975) Single daily dose of allopurinol. Ann. Rheum. Dis., 34, 256–9.

    Article  PubMed  CAS  Google Scholar 

  • Brogard, J. M., Frankhauser, J. and Stahl, A. (1973) Application de l’uricolyse enzymatique au traitement des hyperuricemies d’origine renal. Schweizer. Med. Wochens., 103, 404–10.

    CAS  Google Scholar 

  • Buchanan, W. W., Klinenberg, J. R. and Seegmiller, J. E. (1965) The inflammatory response to injected microcrystalline monosodium urate in normal, hyperuricaemic, gouty and uremic subjects. Arth. Rheum., 8, 361.

    Article  CAS  Google Scholar 

  • Burns, J. J., Yü, T-F. and Berger, L. (1958) Zoxazolamine: physiological disposition, uricosuric properties. Am. J. Med., 25, 401–8.

    Article  PubMed  CAS  Google Scholar 

  • Cannon, P. J., Heinemann, H. O., Stason, W. B. and Laragh, J. H. (1965) Ethacrynic acid. Effectiveness and mode of diuretic action in man. Circulation, 31, 5–18.

    Article  PubMed  CAS  Google Scholar 

  • Cartier, P. H. and Hamet, M. (1973) Mechanism of antiuric action of 4-oxy and 4thiopyrazolopyrimidines. Biochem. Pharmacol., 22, 3061–75.

    Article  PubMed  CAS  Google Scholar 

  • Caruso, I., Fumagalli, M., Marcolongo, R. and Sacchetti, G. (1977) Indoprofen for acute gouty arthritis (letter). Arthr. Rheum., 20, 1438–9.

    Article  CAS  Google Scholar 

  • Coombs, F. S., Pecora, L. J., Thorogood, E. et al. (1940) Renal function in patients with gout. J. Clin. Invest., 19, 525–35.

    Article  PubMed  CAS  Google Scholar 

  • Cuq, P. (1973) Experience française du traitement de la crise de goutte aigue par le naproxen-C1674. Scand. J. Rheumatol., (Suppl.) 2, 64–8.

    Article  CAS  Google Scholar 

  • Delbarre, F., Auscher, C., Gery, A., Brouilheb, H. and Olivier, J. L. (1968) Le traitement de la dyspurinie goutteuse par la mercaptopyrazolopyrimidine (MPP: thiopurinol). Presse Med., 76, 2329–32.

    PubMed  CAS  Google Scholar 

  • Demartini, F. E. (1965) Hyperuricaemia induced by drugs. Arthr. Rheum., 8, 823–9.

    Article  CAS  Google Scholar 

  • De Seze, S., Ryckewaert, A., Caroit, M. et al. (1964) Congres International de la Goutte et de la Lithiase Urique. Sept. 4, Evian, p. 297.

    Google Scholar 

  • Dixon, A. St. J. (1963) Salicylates and uric acid excretion, in Salicylates. An International Symposium (eds A. St. J. Dixon, B. K. Martin, M. J. H. Smith and P. H. N. Ward), Churchill Livingstone, London, p. 38.

    Google Scholar 

  • Dreyfuss, F. (1960) The role of hyperuricaemia in coronary heart disease. Dis. Chest, 38, 332–4.

    Article  PubMed  CAS  Google Scholar 

  • Eidlitz, M. (1961) Uric acid and arteriosclerosis. Lancet, ii, 1046–7.

    Article  Google Scholar 

  • Elion, G. B., Kovensky, A. and Hitchings, G. H. et al. (1966) Metabolic studies of allopurinol, an inhibitor of xanthine oxidase. Biochem. Pharmacol., 15, 863–80.

    Article  PubMed  CAS  Google Scholar 

  • Emmerson, B. T. (1963) A comparison of uricosuric agents in gout, with special reference to sulphinpyrazone. Med. J. Austr., 50, 839–44.

    Google Scholar 

  • Ferris, T. F., Morgan, W. S. and Levitin, H. (1961) Nephrotic syndrome caused by probenecid. N. Engl. J. Med., 265, 381–3.

    Article  PubMed  CAS  Google Scholar 

  • Fessel, W. J. (1972) Hyperuricaemia in health and disease. Seminars Arthr. Rheum., 1, 275.

    Article  CAS  Google Scholar 

  • Fessel, W. J. (1979) Renal outcomes of gout and hyperuricaemia. Am. J. Med., 67, 74–82.

    Article  PubMed  CAS  Google Scholar 

  • Fox, I. H. (1977) Hypouricaemic agents in the treatment of gout, in Clinics in Rheumatic Diseases, Vol. 3, No. 1. Crystal Induced Arthropathies (ed W. N. Kelley), Saunders, London, p. 148.

    Google Scholar 

  • Glick, E. N. (1961) Sulphinpyrazone in the treatment of arthritis associated with hyperuricaemia. Proc. R. Soc. Med., 54, 423–6.

    PubMed  CAS  Google Scholar 

  • Graham, R. and Scott, J. T. (1970) Clinical survey of 354 patients with gout. Ann. Rheum. Dis., 29, 461–8.

    Article  Google Scholar 

  • Greenberg, M. S. and Zambarano, S. S. (1972) Aplastic agranulocytosis after allopurinol therapy. Arthr. Rheum., 15, 413–6.

    Article  CAS  Google Scholar 

  • Gutman, A. B. and Yü, T-F. (1951) Benemid (p-(di-n-propylsulfamyl)-benzoid acid) as uricosuric agent in chronic gouty arthritis. Trans. Assoc. Am. Phys., 64, 279–88.

    PubMed  CAS  Google Scholar 

  • Gutman, A. B. and Yü, T-F. (1952) Gout, a derangement of purine metabolism. Adv. Inter. Med., 5, 227.

    CAS  Google Scholar 

  • Gutman, A. B. and Yü, T-F. (1955) Prevention and treatment of chronic gout. J. Am. Med. Assoc., 157, 1096–102.

    Article  PubMed  CAS  Google Scholar 

  • Hall, A. P. (1965) Correlations among hyperuricaemia, hypercholesterolism, coronary disease and hypertension. Arthr. Rheum., 8, 846–52.

    Article  CAS  Google Scholar 

  • Hall, A. P., Barry, P. E., Dawber, T. R. and McNamara, P. M. (1967) Epidemiology of gout and hyperuricaemia. A long-term population study. Am. J. Med., 42, 27–37.

    Article  PubMed  CAS  Google Scholar 

  • Hansen, O. E. (1966) Hyperuricaemia, gout and atherosclerosis. Am. Heart J., 72, 570–3.

    Article  PubMed  CAS  Google Scholar 

  • Hensen, O. E. and Holten, C. (1958) Uricosuric effect of dicoumarol. Lancet, i, 1047–8.

    Article  Google Scholar 

  • Hart, F. D. and Boardman, P. L. (1963) Indomethacin: a new non-steroid antiinflammatory agent. Br. Med. J., 2, 965–70.

    Article  PubMed  CAS  Google Scholar 

  • Hertz, P., Yager, H. and Richardson, J. A. (1972) Probenecid-induced nephrotic syndrome. Arch. Pathol., 94, 241.

    PubMed  CAS  Google Scholar 

  • Holmes, E. W. (1977) Pathogenesis of hyperuricaemia in primary gout, in Clinics in Rheumatic Diseases, Vol. 3, No. 1. Crystal-Induced Arthropathies (ed. W. N. Kelley), Saunders, London, p. 15.

    Google Scholar 

  • Hutchinson, J. C. and Wilkinson, W. H. (1973) The uricosuric action of halofenate (MK-185) in patients with hyperuricaemia or uncomplicated primary gout and hyperlipidemia. Atherosclerosis, 18, 353–62.

    Article  Google Scholar 

  • Irby, R., Toone, E. and Owen, D. (1966) Bone marrow depression associated with allopurinol therapy. Arthr. Rheum., 9, 860.

    Google Scholar 

  • Jain, A. K., Ryan, J. R. and McMahon, F. G. (1976) Comparison of ticrynafen and probenecid in treatment of hyperuricemia. Clin. Res., 24, 43A.

    Google Scholar 

  • Jakovcic, S. and Sorensen, C. B. (1967) Studies of uric acid metabolism in glycogen storage disease associated with gouty arthritis. Arthr. Rheum., 10, 129–34.

    Article  CAS  Google Scholar 

  • Jarzobski, J., Ferry, J., Wombolt, D., Fitch, D. M. and Egan, J. D. (1970) Vasculitis with allopurinol therapy. Am. Heart J., 79, 116–21.

    Article  PubMed  CAS  Google Scholar 

  • Johnson, H. P., Engleman, E. P., Forsham, P. H. et al. (1954) Effects of phenylbutazone in gout. N. Engl. J. Med., 250, 665.

    Article  PubMed  CAS  Google Scholar 

  • Kaegi, A., Pineo, G. F., Shimizu, A., Trivedi, H., Hirsh, J. and Gent, M. (1974) Arteriovenous-shunt thrombosis: prevention by sulfinpyrazone. N. Engl. J. Med., 290, 304–6.

    Article  PubMed  CAS  Google Scholar 

  • Kantor, G. L. (1970) Toxic epidermal necrolysis, azotemia, and death after allopurinol therapy. J. Am. Med. Assoc., 212, 478–9.

    Article  CAS  Google Scholar 

  • Kaplan, H. (1960) Sarcoid arthritis with a response to colchicine. N. Engl. J. Med., 263, 778–81.

    Article  PubMed  CAS  Google Scholar 

  • Kelley, W. N. (1975a) Effects of drugs on uric acid in man. Ann. Rev. Pharmacol., 15, 327–50.

    Article  PubMed  CAS  Google Scholar 

  • Kelley, W. N. (1975b) Pharmacologic approach to the maintenance of urate homeostasis. Nephron, 14, 99–115.

    Article  PubMed  CAS  Google Scholar 

  • Kelley, W. N. (1979) Treatment of hyperuricemia, in Arthritis and Allied Conditions. A Textbook of Rheumatology (ed D. J. McCarty), 9th edn, Lea and Febiger, Philadelphia, p. 1231.

    Google Scholar 

  • Kelley, W. N., Greene, M. L., Rosenbloom, F. M., Henderson, J. F. and Seegmiller, J. E. (1969) Hypoxanthine-gnomic phosphoribosyltransferase deficiency in gout. Ann. Intern. Med., 70, 155–206.

    Article  PubMed  CAS  Google Scholar 

  • Kelley, W. N., Rosenbloom, E. M., Henderson, J. F. et al. (1967) A specific enzyme defect in gout associated with overproduction of uric acid. Proc. Nat. Acad. Sci. USA, 57, 1735.

    Article  PubMed  CAS  Google Scholar 

  • Kelley, W. N. and Wyngaarden, J. B. (1971) Drug treatment of gout. Seminars Drug Treat., 1, 119–47.

    CAS  Google Scholar 

  • Kidd, E. G., Boyce, K. C. and Freyberg, R. H. (1953) Clinical studies of phenylbutazone (Butazolidin) and butapyrine (Irgapyrine) in rheumatoid arthritis, rheumatoid spondylitis and gout. Ann. Rheum. Dis., 12, 20–4.

    Article  PubMed  CAS  Google Scholar 

  • Kissel, P., Mauuary, G., Royer, R. and Toussain, P. (1975) Treatment of malignant haemopathies and urate oxidase. Lancet, 1, 229.

    Article  PubMed  CAS  Google Scholar 

  • Klinenberg, J. R. (1977) The management of asymptomatic hyperuricaemia, in Clinics in Rheumatic Diseases, Vol. 3, No. 1. Crystal-Induced Arthropathies (ed W. N. Kelley), Saunders, London, p. 159.

    Google Scholar 

  • Kuzell, W. C., Glover, R. P., Gibbs, J. O. et al. (1964) Effect of sulfinpyrazone on serum uric acid in gout. A long-term study. Genetics, 19, 894–909.

    CAS  Google Scholar 

  • Kuzell, W. C., Schaffarzick, R. W., Brown, B. and Mankle, E. A. (1952) Phenylbutazone (Butazolidin) in rheumatoid arthritis and gout. J. Am. Med. Assoc., 149, 729–34.

    Article  PubMed  CAS  Google Scholar 

  • Lesch, M. and Nyhan, W. L. (1964) A familial disorder of uric acid metabolism and central nervous system function. Am. J. Med., 36, 561–70.

    Article  PubMed  CAS  Google Scholar 

  • Lidsky, M. D. and Sharp, J. T. (1967) Jaundice with the use of 4-hydroxypyrazolo (3, 4-D) pyrimidine (4-HPP) (Abstract). Arthr. Rheum., 10, 294.

    Google Scholar 

  • Loebl, W. Y. and Scott, J. T. (1974) Withdrawal of allopurinol in patients with gout. Ann. Rheum. Dis., 33, 304–7.

    Article  PubMed  CAS  Google Scholar 

  • MacLachlan, M. J. and Rodnan, G. P. (1967) Effects of food and alcohol in serum uric acid and acute attacks of gout. Am. J. Med., 42, 38–57.

    Article  PubMed  CAS  Google Scholar 

  • McCarty, D. J. (1976) Calcium pyrophosphate dihydrate crystal deposition disease — 1975. Arthr. Rheum., 19, 275–85.

    Article  Google Scholar 

  • McCarty, D. J., Kohn, N. N. and Faires, J. S. (1962) The significance of calcium phosphate crystals in the synovial fluid of arthritis patients: the ‘pseudogout syndrome’. 1. Clinical aspects. Ann. Intern. Med., 56, 711–37.

    Article  CAS  Google Scholar 

  • Merlin, H. E. (1972) Azoospermia caused by colchicine. Fertil. Steril., 23, 180–1.

    PubMed  CAS  Google Scholar 

  • Mills, R. M. (1971) Severe hypersensitivity reactions associated with allopurinol. J. Am. Med. Assoc., 216, 799–802.

    Article  Google Scholar 

  • Myers, A. R., Epstein, F. H., Dodge, H. J. and Mikkelsen, W. M. (1968) The relationship of serum uric acid to risk factors in coronary heart disease. Am. J. Med., 45, 520–8.

    Article  PubMed  CAS  Google Scholar 

  • Nicholls, A., Snaith, M. L. and Scott, J. T. (1973) Effect of oestrogen therapy on plasma and urinary levels of uric acid. Br. Med. J., 1, 449–51.

    Article  PubMed  CAS  Google Scholar 

  • Nicolaier, A. and Dohrn, M. (1908) Ueber die Wirkung von Chinolincarbonsäure und ihrer Derivate auf die Ausscheidung der Harnsaüre. Deutsch Arc. Klin. Med., xciii, 331–5.

    Google Scholar 

  • Norcross, B. M. (1963) Treatment of connective tissue diseases with a new non-steroid compound (indomethacin) (Abstract). Arthr. Rheum., 6, 290.

    Google Scholar 

  • Perd, J. M., Dayton, P. G., Snell, M. M., Yü, T-F. and Gutman, A. B. (1969) Studies of interactions among drugs in man at the renal level: probenecid and sulfinpyrazone. Clin. Pharmacol. Ther., 10, 834–40.

    Google Scholar 

  • Race, T. F., Paes, I. C. and Falcon, W. W. (1970) Intestinal malabsorption induced by oral colchicine. Am. J. Med. Sci., 259, 32–41.

    Article  PubMed  CAS  Google Scholar 

  • Reynolds, E. S., Schlant, R. C., Gonick, H. and Dammin, H. C. (1957) Fatal massive necrosis of the liver as a manifestation of hypersensitivity to probenecid. N. Engl. J. Med., 256, 592–6.

    Article  PubMed  CAS  Google Scholar 

  • Rieselbach, R. E. and Steel, T. H. (1974) Influence of the kidney upon urate haemostasis in health and disease. Am. J. Med., 56, 665–75.

    Article  PubMed  CAS  Google Scholar 

  • Rieselbach, R. E., Sorensen, L. B., Shelp, W. D. and Steele, T. H. (1970) Diminished renal urate secretion per nephron as a basis for primary gout. Ann. Intern. Med., 73, 359–66.

    Article  PubMed  CAS  Google Scholar 

  • Rubulis, A., Rubert, M. and Faloon, W. W. (1970) Cholesterol lowering, fecal bile and sterol changes during neomycin and colchicine. J. Clin. Nutr., 23, 1251–9.

    CAS  Google Scholar 

  • Schweitz, M. C., Nashel, D. J. and Alepa, F. P. (1978) Ibuprofen in the treatment of acute gouty arthritis. J. Am. Med. Assoc., 239, 34–5.

    Article  CAS  Google Scholar 

  • Scott, J. T. (1978) Gout, in Copeman’s Textbook of the Rheumatic Diseases (ed J. T. Scott), 5th edn, Churchill Livingstone, Edinburgh, pp. 647–91.

    Google Scholar 

  • Scott, J. T. (1980) Long-term management of gout and hyperuricaemia. Br. Med. J., 281, 1164–6.

    Article  PubMed  CAS  Google Scholar 

  • Scott, J. T. and O’Brien, P. K. (1968) Probenecid, nephrotic syndrome and renal failure. Ann. Rheum. Dis., 27, 249–52.

    Article  PubMed  CAS  Google Scholar 

  • Seegmiller, J. E. and Howell, R. R. (1962) The old and new concepts of acute gouty arthritis. Arthr. Rheum., 5, 616–23.

    Article  CAS  Google Scholar 

  • Seegmiller, J. E., Rosenbloom, R. M. and Kelley, W. N. (1967) An enzyme defect associated with a sex-linked human neurological disorder and excessive purine synthesis. Science, 155, 1682.

    Article  PubMed  CAS  Google Scholar 

  • Simmons, F., Feldman, B. and Gerety, D. (1972) Granulomatous hepatitis in a patient receiving allopurinol. Gastroenterology, 62, 101–4.

    PubMed  CAS  Google Scholar 

  • Skinner, M. and Cohen, A. S. (1969) Calcium pyrophosphate dihydrate crystal deposition disease. Arch. Intern. Med., 123, 636–64.

    Article  PubMed  CAS  Google Scholar 

  • Sokol, A., Bashner, M. H. and Okun, R. (1967) Nephrotic syndrome caused by probenecid. J. Am. Med. Assoc., 199, 43.

    Article  CAS  Google Scholar 

  • Smyth, C. J. (1970) Indomethacin — its rightful place in treatment. Ann. Intern. Med., 72, 430–2.

    Article  PubMed  CAS  Google Scholar 

  • Smyth, C. J. (1972) Diagnosis and treatment of gout, in Arthritis and Allied Conditions (eds J. L. Hollander and D. J. McCarty), 8th edn, Lea and Febiger, Philadelphia, pp. 1112–39.

    Google Scholar 

  • Smyth, C. J., Velayos, E. E. and Amorosa, C. (1963) A method for measuring swelling of hands and feet. II. Influence of new anti-inflammatory drug, indomethacin in acute gout. Acta Rheumatol. Scand., 9, 306.

    Article  PubMed  CAS  Google Scholar 

  • Sougin-Mibashan, R. and Horwitz, M. (1955) The uricosuric action of ethyl biscoumacetate. Lancet, i, 1191–7.

    Article  Google Scholar 

  • Stason, W. B., Cannon, P. J., Heinemann, H. O. and Laragh, J. H. (1966) Furosemide. A clinical evaluation of its diuretic action. Circulation, 34, 910–20.

    Article  PubMed  CAS  Google Scholar 

  • Steele, T. H. (1977) Diuretic-induced hyperuricaemia, in Clinics in Rheumatic Diseases, Vol. 3, No. 1. Crystal-Induced Arthropathies (ed W. N. Kelley), Saunders, London, p. 44.

    Google Scholar 

  • Straitigos, J. D., Bartosokas, S. K. and Capetanakis, J. (1972) Further experiences of toxic epidermal necrolysis incriminating allopurinol, pyrazolone and derivatives. Br. J. Dermatol., 86, 564–7.

    Article  Google Scholar 

  • Sturge, R. A., Scott, J. T., Hamilton, E. B. D., Liyanage, S. P., Dixon, A. St. J., Davies, J. and Engler, C. (1977) Multicentre trial of naproxen and phenylbutazone in acute gout. Ann. Rheum. Dis., 36, 80–2.

    Article  PubMed  CAS  Google Scholar 

  • Talbott, J. H. (1943) Gout, Oxford University Press, London.

    Google Scholar 

  • Talbott, J. H. (1964) Gout, 2nd edn, Grune and Stratton, New York, p. 206.

    Google Scholar 

  • Thompson, G. R., Ting, Y. M., Riggs, G. A., Fenn, M. E. and Denning, R. M. (1968) Calcific tendinitis and soft tissue calcification resembling gout. J. Am. Med. Assoc., 203, 464–72.

    Article  CAS  Google Scholar 

  • Tjandramaga, T. B., Cucinell, S. A., Israile, Z. H. et al. (1972) Observations on the disposition of probenecid in patients receiving allopurinol. Pharmacology, 8, 259–72.

    Article  PubMed  CAS  Google Scholar 

  • Wallace, S. L. (1972) The treatment of gout. Arthr. Rheum., 15, 317–23.

    Article  CAS  Google Scholar 

  • Wallace, S. L. (1975) Colchicine and new antiinflammatory drugs for the treatment of acute gout. Arthr. Rheum., 18, 847–51.

    Article  CAS  Google Scholar 

  • Wallace, S. L. (1977) The treatment of the acute attack of gout, in Clinics in Rheumatic Diseases, Vol. 3, No. 1. Crystal-Induced Arthropathies (ed W. N. Kelley), Saunders, London, p. 138.

    Google Scholar 

  • Wallace, S. L., Bernstein, D. and Diamond, H. (1967) Diagnostic value of the colchicine therapeutic trial. J. Am. Med. Assoc., 199, 525–8.

    Article  CAS  Google Scholar 

  • Wanasukapunt, S., Lertratanakul, Y. and Rubinstein, H. M. (1976) Effect of fenoprofen calcium on acute gouty arthritis. Arthr. Rheum., 19, 933–8.

    Article  CAS  Google Scholar 

  • Webb, D. I., Chodos, R. B., Mahar, C. Q. and Faloon, W. W. (1968) Mechanism of vitamin B12 malabsorption in patients receiving colchicine. N. Engl. J. Med., 279, 845–50.

    Article  PubMed  CAS  Google Scholar 

  • Willkens, R. F. and Case, J. B. (1973) Treatment of acute gout with naproxen. Scand. J. Rheumatol. (Suppl.) 2, 69–72.

    Article  CAS  Google Scholar 

  • Willkens, R. F., Case, J. B. and Huix, F. J. (1976) Treatment of acute gout with naproxen. J. Clin. Pharmacol., 16, 363–7.

    Google Scholar 

  • Wyngaarden, J. B. and Kelley, W. N. (1972) Gout, in The Metabolic Basis of Inherited Disease, 3rd edn (eds J. B. Stanbury, J. B. Wyngaarden and D. S. Fredrickson), McGraw Hill, New York, p. 889.

    Google Scholar 

  • Wyngaarden, J. B. and Kelley, W. N. (1976) Clinical syndromes associated with hypoxanthine-guanine phosphoribosyltransferase deficiency, in Gout and Hyperuricemia, Grune and Stratton, New York, pp. 309–44.

    Google Scholar 

  • Yü, T. (1974) Milestones in the treatment of gout. Am. J. Med., 56, 676–85.

    Article  PubMed  Google Scholar 

  • Yü, T-F. and Gutman, A. B. (1961) Efficacy of colchicine prophylaxis in gout. Ann. Intern. Med., 55, 179–92.

    Article  PubMed  Google Scholar 

  • Yü, T-F., Berger, L. and Gutman, A. B. (1968) Hypoglycemia and uricosuric properties of acetohexamide and hydroxyhexamide. Metabolism, 17, 309–16.

    Article  PubMed  Google Scholar 

Download references

Authors
  1. J. M. H. Moll
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Sheffield Centre for Rheumatic Diseases, Nether Edge Hospital, Sheffield, UK

    J. M. H. Moll BSc DM PhD FRCP (Consultant physician in Rheumatology and Head, Honorary Clinical Lecturer in Rheumatic Diseases) (Consultant physician in Rheumatology and Head, Honorary Clinical Lecturer in Rheumatic Diseases)

  2. University of Sheffield, UK

    J. M. H. Moll BSc DM PhD FRCP (Consultant physician in Rheumatology and Head, Honorary Clinical Lecturer in Rheumatic Diseases) (Consultant physician in Rheumatology and Head, Honorary Clinical Lecturer in Rheumatic Diseases)

  3. General Infirmary at Leeds, University Department of Medicine, UK

    H. A. Bird MA MD FRCP (Lecturer in Rheumatology, Honorary Consultant Rheumatologist) (Lecturer in Rheumatology, Honorary Consultant Rheumatologist)

  4. General Infirmary at Leeds and Royal Bath Hospital, Harrogate, UK

    H. A. Bird MA MD FRCP (Lecturer in Rheumatology, Honorary Consultant Rheumatologist) (Lecturer in Rheumatology, Honorary Consultant Rheumatologist)

  5. Clinical Research Department, Imperial Chemical Industries PLC, Pharmaceuticals Division, Alderley Park, Macclesfield, UK

    A. Rushton MB ChB MRCP (Drug team leader) (Drug team leader)

Rights and permissions

Reprints and permissions

Copyright information

© 1986 J. M. H. Moll, H. A. Bird and A. Rushton

About this chapter

Cite this chapter

Moll, J.M.H. (1986). Gout and other crystal-deposition disorders. In: Moll, J.M.H., Bird, H.A., Rushton, A. (eds) Therapeutics in Rheumatology. Springer, Boston, MA. https://doi.org/10.1007/978-1-4899-2883-2_14

Download citation

  • DOI: https://doi.org/10.1007/978-1-4899-2883-2_14

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-0-412-24540-4

  • Online ISBN: 978-1-4899-2883-2

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation